2-aminobicyclo(2,2,1)heptane-2-carboxylic acid has been researched along with Astrocytoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Endou, H; Fukui, S; Kanai, Y; Matsuo, H; Nawashiro, H; Ooigawa, H; Otani, N; Shima, K; Shinomiya, N | 1 |
1 other study(ies) available for 2-aminobicyclo(2,2,1)heptane-2-carboxylic acid and Astrocytoma
Article | Year |
---|---|
L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amino Acids, Cyclic; Animals; Astrocytoma; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Child; Female; Fusion Regulatory Protein 1, Heavy Chain; Glioma; Humans; Immunohistochemistry; Infant, Newborn; Large Neutral Amino Acid-Transporter 1; Male; Middle Aged; Neoplasms, Experimental; Rats; Rats, Wistar; Survival Analysis; Survival Rate | 2006 |